Table 1 Baseline characteristics of the study population by group
From: The role of soluble fiber intake in patients under highly effective lipid-lowering therapy
RSV+Fib | RSV | SIM/EZE+Fib | SIM+EZE | P-value | |
|---|---|---|---|---|---|
N = 28 | N = 30 | N = 28 | n = 30 | ||
Age, years1 | 57 (1) | 60 (2) | 62 (1) | 58 (1) | 0.21 |
Female, n (%)2 | 21 (75) | 20 (67) | 19 (68) | 22 (73) | 0.87 |
Hypertension, n (%)2 | 22 (79) | 24 (80) | 18 (64) | 26 (87) | 0.22 |
Diabetes, n (%)2 | 5 (18) | 7 (23) | 6 (21) | 9 (30) | 0.73 |
Smoking, n (%)2 | 2 (7) | 3 (10) | 1 (4) | 2 (7) | 0.82 |
Metabolic Syndrome, n (%)2 | 17 (61) | 18 (60) | 13 (46) | 14 (47) | 0.53 |